…this will… be the first time in 25 years that the FDA will review a new treatment for PTSD… The FDA is set to decide on the therapy’s fate by the middle of August [2024]… if rescheduled, then lobbying efforts will shift to individual states. Some have policies on the books that will immediately follow…
At first, the goal was to use psychedelics to heal veterans (as indicated by MAPS’s public relations between 2005 and 2012). Then, in 2012, Doblin shifted to suggesting that psychedelics might be used to heal traumatized active-duty soldiers. Now, MAPS’s founder calls for military recruits to be dosed upon enlistment. This latest turn was announced…
It would be one thing if arguments against the decriminalization of psychedelics were being made. But that’s not the case. Instead, the lumping together of psychedelics and opioids seems to have gone largely unnoticed, setting up personal use of psychedelics to become an unintended casualty of Oregon’s opioid crisis. By treating all drugs as an…
[Oregon is poised to legislate the return to recriminalizing personal possession of psilocybin-containing mushrooms (as well as LSD and MDMA) on Tuesday March 12, 2024; with citizens awaiting Democratic Governor Tina Kotek’s signature to do so.] “There is more awareness when it comes to psychedelics, especially mushrooms,” Valera said. Salem City Councilor Andy Varela believes…
MAPS PBC [Public Benefit Corporation) has rebranded to Lykos Therapeutics [a for-profit public benefit corporation (“PBC”)], (“Lykos”), the greek word for wolf. MAPS PBC spun out of its parent organization MAPS (Multidisciplinary Association for Psychedelic Studies)… clinical development effort of MDMA-assisted therapy [midomafetamine capsules used in combination with psychological intervention], which includes talk therapy, and…
The MAPS Public Benefit Corporation (MAPS PBC) announced on Tuesday [12/12/23] that it submitted the new drug application (NDA) to FDA, requesting an expedited review given that the agency previously designated the psychedelic as a breakthrough therapy. If the NDA is ultimately approved, the Drug Enforcement Administration (DEA) would then need to reschedule MDMA accordingly.…
…calls to permit their use in psychotherapy have been growing in Ukraine following Russia’s full-scale invasion. Experts in Ukraine are appealing to parliament to facilitate the therapeutic use of these substances. Ksenia Voznitsyna, director of the Ukrainian Health Ministry’s Center for Veterans’ Mental Health and Rehabilitation, is a leading voice in the campaign. “We are…
Juvenile mice find social experiences more rewarding than do adults. The discovery [is] that psychedelics can re-engage the social neural circuits for varying durations in adults… Gül Dölen, M.D., Ph.D., associate professor of neuroscience at the Johns Hopkins University School of Medicine.; …ibogaine, ketamine, LSD, MDMA, and psilocybin, can reopen the “critical periods” of brain…
A Vancouver man, Jerry Martin… opened the Drugs Store… the only known brick-and-mortar store in Canada and the U.S. that sells heroin, cocaine, meth, MDMA, and other drugs… he opened the store because he wants to give people drugs that have been tested and are free from adulterants… fourier-transform infrared spectroscopy machine… His hope is…
The American Medical Association (AMA) is expected to issue the first code for psychedelic therapy reimbursement, following the approval of a joint application submitted by MAPS PBC [partnered with MAPS and Rick Doblin] and [Peter Theil & Christian Angermayer backed] COMPASS Pathways… On March 3 [2023], the AMA published its Panel Actions summary which included…
Recent Comments